Previous Close | 0.83 |
1-Year Change | -4.6% |
6-Months Change | 7.79% |
3-Months Change | 84.44% |
Moving Avg (50d) | 0.7464 |
Moving Avg (200d) | 0.6333 |
ESG Rating | - |
Exchange | NASDAQ |
Market Cap. | 147.1M |
Beta (3-Years) | 1.6 |
Revenue Growth (ttm) | 79.75% |
Net Profit Margin (ttm) | -123.89% |
Return On Assets (ttm) | -113.58% |
EPS (ttm) | -1.45 |
PE Ratio (ttm) | -0.57 |
Dividend Yield | % |
Asset Description: | Sangamo Therapeutics, Inc. |
Predicted Direction: | Sell |
Signal Strength: | Sell |
Forecast Date: | 2024-09-11 00:00:00 |
Strong Buy | ||
Buy | ||
Neutral | ||
Sell | ||
Strong Sell |
2% | 5% | 7% | 10% | 15% | 20% |
0.847 | 0.871 | 0.888 | 0.913 | 0.954 | 0.996 |
Disclaimer - Please note that the use of AI to analyse contents may occasionally generate incorrect information.
Our cutting-edge algorithms employ macroeconomic data, fundamental and technical analysis indicators to accurately predict the optimal position for short-term trading
By harnessing these signals, we power our asset allocation tools, backtesting tool and portfolio management process, ensuring maximum returns for your investments.